# Arthrosi funding rounds and investors

As of 14 Oct 2026, Arthrosi has raised $153M across 1 verified round on record; latest: $153 million Series E led by Prime Eight Capital, announced 8 Oct 2025.

They develop therapies for gout and chronic kidney disease, primarily targeting gout patients.

Website: https://arthrosi.com  
Headquarters: San Diego, CA  
Page: https://fireround.dev/companies/arthrosi.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-10-08 | Series E | $153 million | Prime Eight Capital | CR Biotech, Highlight Capital, HM Venture Partners, ReliantTech Limited | [prnewswire.com](https://www.prnewswire.com/news-releases/arthrosi-secures-153-million-in-series-e-financing-to-complete-pivotal-development-of-pozdeutinurad-for-the-treatment-of-gout-and-tophaceous-gout-302578248.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.